| The genomic landscape of juvenile myelomonocytic leukemia E Stieglitz, AN Taylor-Weiner, TY Chang, LC Gelston, YD Wang, T Mazor, ... Nature genetics 47 (11), 1326-1333, 2015 | 272 | 2015 |
| Genomic subtyping and therapeutic targeting of acute erythroleukemia I Iacobucci, J Wen, M Meggendorfer, JK Choi, L Shi, SB Pounds, ... Nature genetics 51 (4), 694-704, 2019 | 118 | 2019 |
| Genetic predispositions to childhood leukemia E Stieglitz, ML Loh Therapeutic advances in hematology 4 (4), 270-290, 2013 | 112 | 2013 |
| Distinct genetic pathways define pre-malignant versus compensatory clonal hematopoiesis in Shwachman-Diamond syndrome AL Kennedy, KC Myers, J Bowman, CJ Gibson, ND Camarda, E Furutani, ... Nature communications 12 (1), 1334, 2021 | 103 | 2021 |
| Subclonal mutations in SETBP1 confer a poor prognosis in juvenile myelomonocytic leukemia E Stieglitz, CB Troup, LC Gelston, J Haliburton, ED Chow, KB Yu, ... Blood, The Journal of the American Society of Hematology 125 (3), 516-524, 2015 | 99 | 2015 |
| Genome-wide DNA methylation is predictive of outcome in juvenile myelomonocytic leukemia E Stieglitz, T Mazor, AB Olshen, H Geng, LC Gelston, J Akutagawa, ... Nature communications 8 (1), 2127, 2017 | 83 | 2017 |
| Robust patient-derived xenografts of MDS/MPN overlap syndromes capture the unique characteristics of CMML and JMML A Yoshimi, ME Balasis, A Vedder, K Feldman, Y Ma, H Zhang, SCW Lee, ... Blood, The Journal of the American Society of Hematology 130 (4), 397-407, 2017 | 80 | 2017 |
| International interlaboratory digital PCR study demonstrating high reproducibility for the measurement of a rare sequence variant AS Whale, AS Devonshire, G Karlin-Neumann, J Regan, L Javier, ... Analytical chemistry 89 (3), 1724-1733, 2017 | 70 | 2017 |
| Phase II/III trial of a pre‐transplant farnesyl transferase inhibitor in juvenile myelomonocytic leukemia: A report from the Children's Oncology Group E Stieglitz, AF Ward, RB Gerbing, TA Alonzo, RJ Arceci, YL Liu, ... Pediatric blood & cancer 62 (4), 629-636, 2015 | 63 | 2015 |
| Activating mutations of RRAS2 are a rare cause of Noonan syndrome Y Capri, E Flex, OHF Krumbach, G Carpentieri, S Cecchetti, C Lißewski, ... The American Journal of Human Genetics 104 (6), 1223-1232, 2019 | 52 | 2019 |
| International consensus definition of DNA methylation subgroups in juvenile myelomonocytic leukemia M Schönung, J Meyer, P Nöllke, AB Olshen, M Hartmann, N Murakami, ... Clinical Cancer Research 27 (1), 158-168, 2021 | 45 | 2021 |
| Surface Proteomics Reveals CD72 as a Target for In Vitro–Evolved Nanobody-Based CAR-T Cells in KMT2A/MLL1-Rearranged B-ALL MA Nix, K Mandal, H Geng, N Paranjape, YHT Lin, JM Rivera, ... Cancer discovery 11 (8), 2032-2049, 2021 | 41 | 2021 |
| Clinical utilization of blinatumomab and inotuzumab immunotherapy in children with relapsed or refractory B‐acute lymphoblastic leukemia CF Contreras, CS Higham, A Behnert, K Kim, E Stieglitz, SK Tasian Pediatric blood & cancer 68 (1), e28718, 2021 | 38 | 2021 |
| Precision cancer monitoring using a novel, fully integrated, microfluidic array partitioning digital PCR platform ME Dueck, R Lin, A Zayac, S Gallagher, AK Chao, L Jiang, SS Datwani, ... Scientific reports 9 (1), 19606, 2019 | 37 | 2019 |
| MEK inhibitors for neurofibromatosis type 1 manifestations: Clinical evidence and consensus PMK De Blank, AM Gross, S Akshintala, JO Blakeley, G Bollag, A Cannon, ... Neuro-oncology 24 (11), 1845-1856, 2022 | 35 | 2022 |
| Disease burden and conditioning regimens in ASCT1221, a randomized phase II trial in children with juvenile myelomonocytic leukemia: A Children's Oncology Group study CC Dvorak, P Satwani, E Stieglitz, MS Cairo, H Dang, Q Pei, Y Gao, ... Pediatric blood & cancer 65 (7), e27034, 2018 | 35 | 2018 |
| Molecular and phenotypic diversity of CBLmutated juvenile myelomonocytic leukemia A Hecht, JA Meyer, A Behnert, E Wong, F Chehab, A Olshen, A Hechmer, ... Haematologica 107 (1), 178, 2022 | 28 | 2022 |
| Fusion driven JMML: a novel CCDC88C–FLT3 fusion responsive to sorafenib identified by RNA sequencing AK Chao, JA Meyer, AG Lee, A Hecht, T Tarver, J Van Ziffle, AK Koegel, ... Leukemia 34 (2), 662-666, 2020 | 26 | 2020 |
| Matched targeted therapy for pediatric patients with relapsed, refractory, or high-risk leukemias: a report from the LEAP Consortium Y Pikman, SK Tasian, ML Sulis, K Stevenson, TM Blonquist, ... Cancer discovery 11 (6), 1424-1439, 2021 | 25 | 2021 |
| The impact of total body irradiation‐based regimens on outcomes in children and young adults with acute lymphoblastic leukemia undergoing allogeneic hematopoietic stem cell … BD Friend, M Bailey‐Olson, A Melton, KA Shimano, S Kharbanda, ... Pediatric blood & cancer 67 (2), e28079, 2020 | 25 | 2020 |
